… ponatinib (Iclusig), sorafenib (Nexavar), ceritinib (Zykadia), and … at leptomeningeal disease from breast cancer, lung cancer, and … We are looking at breast cancer, specifically. In our … treat patients with breast cancer and leptomeningeal disease. …

… .2-18.5) with sorafenib (Nexavar) in patients with previously untreated … , including liver, lung, gastric, and breast cancer. This agent is approved in …

… benefit compared with sorafenib (Nexavar) for patients with advanced … low breast cancer (n = 713) and HER2–ultra-low breast cancer (n … –ultra-low metastatic breast cancers may benefit from … -her2-low-metastatic-breast-cancer Trastuzumab deruxtecan significantly …

… in the VRd group).14 Breast Cancer Phase 3 DESTINY-Breast06 Trial … +, in situ hybridization negative) metastatic breast cancer following 1 or more lines … with either lenvatinib or sorafenib (Nexavar; Bayer). The ORR was 36% …

… low or HER2-ultralow breast cancer patients who have … low or HER2-ultralow breast cancer. The designation is … -positive metastatic breast cancer and HER2-low metastatic breast cancer. Elsewhere, … Lenvima or Bayer’s Nexavar. Specifically, patients who …

… a certain kind of metastatic breast cancer (patients with low expression of … from Merck and Eisai or Nexavar from Bayer) in patients with …

… Sirtex Medical Limited Sorafenib (Nexavar) Taiho Pharmaceutical Co. Ltd … By Type of Cancer (Breast Cancer, Lung Cancer, Brain … Others), By Cancer Type (Breast Cancer, Lung Cancer, Prostate Cancer … By Type of Cancer (Breast Cancer, Lung Cancer, Prostate Cancer …

… is sorafenib, also known as Nexavar or sorafenib tosylate, which has … the growth and metastasis of breast cancer in mice. Phytother Res. 2021 … or trastuzumab in patients with breast cancer. Eur Heart J. 2022;43 …

… , cervical cancer, nasopharyngeal carcinoma and breast cancer.79 TCM plays a more … the multi-kinase inhibitor sorafenib (Nexavar) is an oral drug and …